Your browser doesn't support javascript.
loading
Hippo-YAP1 Is a Prognosis Marker and Potentially Targetable Pathway in Advanced Gallbladder Cancer.
García, Patricia; Rosa, Lorena; Vargas, Sergio; Weber, Helga; Espinoza, Jaime A; Suárez, Felipe; Romero-Calvo, Isabel; Elgueta, Nicole; Rivera, Vanessa; Nervi, Bruno; Obreque, Javiera; Leal, Pamela; Viñuela, Eduardo; Aguayo, Gloria; Muñiz, Sabrina; Sagredo, Alfredo; Roa, Juan C; Bizama, Carolina.
Afiliação
  • García P; Department of Pathology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 8330024, Chile.
  • Rosa L; Department of Pathology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 8330024, Chile.
  • Vargas S; Applied Molecular and Cellular Biology PhD Program, Universidad de La Frontera, Temuco 4811230, Chile.
  • Weber H; Department of Hematology Oncology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 8331150, Chile.
  • Espinoza JA; Centre of Excellence in Translational Medicine (CEMT) and Scientific and Technological Bioresource Nucleus (BIOREN), Universidad de la Frontera, Temuco 4810296, Chile.
  • Suárez F; SciLifeLab, Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, 17165 Stockholm, Sweden.
  • Romero-Calvo I; Department of Pathology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 8330024, Chile.
  • Elgueta N; Biomedical Visualization Graduate Program, Department of Biomedical and Health Information Sciences. College of Applied Health Sciences. University of Illinois at Chicago, Chicago, IL 60607, USA.
  • Rivera V; Department of Pathology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 8330024, Chile.
  • Nervi B; Department of Pathology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 8330024, Chile.
  • Obreque J; Department of Hematology Oncology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 8331150, Chile.
  • Leal P; Department of Pathology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 8330024, Chile.
  • Viñuela E; Centre of Excellence in Translational Medicine (CEMT) and Scientific and Technological Bioresource Nucleus (BIOREN), Universidad de la Frontera, Temuco 4810296, Chile.
  • Aguayo G; Department of Digestive Surgery, Hepato-Bilio-Pancreatic Surgery Unit, Surgery Service, Complejo Asistencial Hospital Dr. Sótero del Río, Santiago 8207257, Chile.
  • Muñiz S; Department of Pathology, Complejo Asistencial Hospital Dr. Sótero del Río, Santiago 8207257, Chile.
  • Sagredo A; Department of Hematology Oncology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 8331150, Chile.
  • Roa JC; Department of Pathology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 8330024, Chile.
  • Bizama C; Department of Pathology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 8330024, Chile.
Cancers (Basel) ; 12(4)2020 Mar 25.
Article em En | MEDLINE | ID: mdl-32218280
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Chile País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Chile País de publicação: Suíça